L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-

Request For Quotation
L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl- Suppliers list
Company Name: Hangzhou Peptidego Biotech Co.,Ltd.  
Tel: 0571-87213919 15967184799
Email: Eric@peptidego.com
Company Name: Guangzhou Younan Technology Co., Ltd  
Tel: 020-82000279 18988941452
Email: YN_research@163.com
Company Name: Hangzhou Sinoda Pharmaceutical Technology Co. LTD  
Tel: 0571-87213919 17306812703
Email: 3007955328@qq.com
Company Name: Nanjing Typeptide Biotechnology Co.,Ltd.  
Tel: 19961912513; 19941518170
Email: sales@typeptide.com
Company Name: Fuan Bio  
Tel: 15002819872
Email: 2845971812@qq.com
L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl- Basic information
Product Name:L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl-
Synonyms:L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl-;Azurin p28;Azurin p28 peptide
CAS:897026-25-4
MF:C122H197N31O47S2
MW:2914.21
EINECS:
Product Categories:
Mol File:897026-25-4.mol
L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl- Structure
L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl- Chemical Properties
Boiling point 2726.3±65.0 °C(Predicted)
density 1.358±0.06 g/cm3(Predicted)
solubility Soluble to 2 mg/ml in 0.01M PBS
form Solid
color White to off-white
SequenceLeu-Ser-Thr-Ala-Ala-Asp-Met-Gln-Gly-Val-Val-Thr-Asp-Gly-Met-Ala-Ser-Gly-Leu-Asp-Lys-Asp-Tyr-Leu-Lys-Pro-Asp-Asp
Safety Information
MSDS Information
L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl- Usage And Synthesis
UsesAzurin p28 peptide is a tumor-penetrated antitumor peptide. Azurin p28 peptide redues proteasomal degradation of p53 through formation of a p28: p53 complex. Azurin p28 peptide induces apoptosis or cell cycle arrest. Azurin p28 peptide inhibits p53-positive tumor growths. Azurin p28 peptide shows antiangiogenic effect by inhibiting phosphorylation of VEGFR-2, FAK and Akt[1][2][3].
storageStore at -20°C
References[1] Jia L, et al. Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemother Pharmacol. 2011 Aug;68(2):513-24. DOI:10.1007/s00280-010-1518-3
[2] Mehta RR, et al. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt. Angiogenesis. 2011 Sep;14(3):355-69. DOI:10.1007/s10456-011-9220-6
[3] Yamada T, et al. A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Mol Cancer Ther. 2009 Oct;8(10):2947-58. DOI:10.1158/1535-7163.MCT-09-0444
L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl- Preparation Products And Raw materials
Tag:L-Aspartic acid, L-leucyl-L-seryl-L-threonyl-L-alanyl-L-alanyl-L-α-aspartyl-L-methionyl-L-glutaminylglycyl-L-valyl-L-valyl-L-threonyl-L-α-aspartylglycyl-L-methionyl-L-alanyl-L-serylglycyl-L-leucyl-L-α-aspartyl-L-lysyl-L-α-aspartyl-L-tyrosyl-L-leucyl-L-lysyl-L-prolyl-L-α-aspartyl-(897026-25-4) Related Product Information
Doxorubicin hydrochloride Ruxolitinib 2-Deoxy-D-glucose Carbonyl cyanide 3-chlorophenylhydrazone LY 294002 Hydrochloride Streptozotocin